31
Mar
2021
17:00
BST
Webinar
Improving Efficiency in Stroke Prevention
-
Views:
5248
-
Likes:
16
Overview
LAA closure (LAAC) is a proven alternative to oral anticoagulation for preventing stroke in patients with non-valvular AF.
Please join this webinar at 6pm CEST / 5pm BST on LAAC Patient Management in the COVID-19 Era to reinforce the importance to treat LAA closure patients, overcome barriers during a pandemic and optimizing an elective procedure with the new LAA closure device WATCHMAN FLX.
Faculty:

David Hildick-Smith

Tim Betts

A John Camm
This webinar is supported by

Agenda
Learning Objectives
- Discuss the emerging evidence for the LAA closure therapy in the era of NOACs.
- Share experience about the management of elective procedures during the pandemic to offer treatment for patients at high risk for stroke.
- Learn how new imaging modalities (ICE, mini-micro TEE, CT) and workstreams could reduce the need for General Anesthesia, streamlining the LAAC procedure and the patient follow-up.
- Learn about the latest LAAC clinical data and the proven safety profile of WATCHMAN FLX.
- Understand how the new implantation technique of WATCHMAN FLX can optimize procedural results.
Audience
- Interventional Cardiologists
- Electrophysiologists
Faculty Biographies

David Hildick-Smith
Prof David Hildick-Smith is Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre - the Regional Specialist Unit.

Tim Betts
John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, UK

A John Camm
John Camm is British Heart Foundation Professor of Clinical Cardiology (Emeritus) at St George’s University of London, London, UK. His interests include cardiac arrhythmias, atrial fibrillation, stroke prevention, and anticoagulation.